C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,607,935 | -19.8% | 864,481 | +18.6% | 0.01% | -16.7% |
| Q2 2023 | $2,004,588 | -11.8% | 728,941 | +0.7% | 0.01% | -14.3% |
| Q1 2023 | $2,272,421 | -47.1% | 723,701 | -0.7% | 0.01% | -51.7% |
| Q4 2022 | $4,299,159 | -33.7% | 728,671 | -1.4% | 0.03% | -43.1% |
| Q3 2022 | $6,481,000 | +61.5% | 738,993 | +38.8% | 0.05% | +64.5% |
| Q2 2022 | $4,014,000 | +353.0% | 532,420 | +2174.0% | 0.03% | +416.7% |
| Q2 2021 | $886,000 | – | 23,413 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |